Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-28

FDA Approved: FIRDAPSE — Original Application (Catalyst Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved FIRDAPSE (amifampridine phosphate) in this original application for Lambert-Eaton myasthenic syndrome, marking the drug's initial approval for the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FIRDAPSE (AMIFAMPRIDINE PHOSPHATE)

Snippet

ORIG AP for FIRDAPSE (AMIFAMPRIDINE PHOSPHATE)